Screener
Nektar Therapeutics NKTR Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current assets (including $432 and $429 as of March 31, 2026 and December 31, 2025, respectively, from a related party) | 20,437 | 20,514 |
| Total current assets | 589,041 | 266,266 |
| Long-term investments | 162,993 | — |
| Other assets | 11,237 | 14,140 |
| Total assets | $763,271 | $280,406 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable (including $504 and $137 as of March 31, 2026 and December 31, 2025, respectively, to a related party) | $10,026 | $10,770 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's deferred tax assets and other non-current assets?
- Nektar Therapeutics (NKTR) reported deferred tax assets and other non-current assets of $11.24M in Q1 2026.
- How has Nektar Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Nektar Therapeutics's deferred tax assets and other non-current assets increased by 108.4% year-over-year, from $5.39M to $11.24M.
- What is the long-term trend for Nektar Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Nektar Therapeutics's deferred tax assets and other non-current assets has grown at a 57.5% compound annual growth rate (CAGR), from $1.46M to $14.14M.
Ask your AI about Nektar Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude